Kobayashi Pharmaceutical Co., Ltd.
KBYPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $438 | $591 | $559 | $717 |
| - Cash | $51 | $72 | $96 | $95 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $388 | $520 | $463 | $622 |
| Revenue | $166 | $173 | $166 | $155 |
| % Growth | -4.5% | 4.3% | 7.1% | – |
| Gross Profit | $88 | $96 | $92 | $89 |
| % Margin | 52.9% | 55.6% | 55.5% | 57.2% |
| EBITDA | $22 | $34 | $32 | $31 |
| % Margin | 13.3% | 19.4% | 19.2% | 19.8% |
| Net Income | $10 | $20 | $20 | $20 |
| % Margin | 6.1% | 11.7% | 12% | 12.7% |
| EPS Diluted | 135.42 | 268.16 | 259.59 | 252.36 |
| % Growth | -49.5% | 3.3% | 2.9% | – |
| Operating Cash Flow | $11 | $18 | $32 | $22 |
| Capital Expenditures | -$27 | -$14 | -$16 | -$4 |
| Free Cash Flow | -$15 | $5 | $16 | $18 |